INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2016
Net Assets |
£223m |
Net Assets per share |
591p |
Share price |
530p |
Total value of unquoted investments |
£25m |
Total number of portfolio companies |
84 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
7.1 |
Regeneron |
6.5 |
Actelion |
4.7 |
Alexion |
4.7 |
Incyte |
4.0 |
Amgen |
3.7 |
Medivation |
3.7 |
Vertex |
3.6 |
Novo |
3.4 |
Biogen |
3.4 |
|
----------- |
Total |
44.8 |
Geographical Allocation |
% NAV |
US & Canada |
75 |
Europe & UK |
25 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
89 |
Unquoted |
11 |
|
----------- |
Total |
100 |
NAV % Market Cap |
% NAV |
Large Cap >USD10BN |
68 |
Small Cap <USD1BN |
26 |
Mid Cap =USD1-10BN |
6 |
|
----------- |
Total |
100 |
NAV % by Therapeutic Areas |
% NAV |
Oncology |
37 |
Orphan |
22 |
CNS |
11 |
Ophthalmology |
8 |
Inflammation |
5 |
Medtech |
2 |
Other |
15 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 AUGUST 2016